Advanced search
Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 38, 2019 - Issue 6
Submit an article Journal homepage
156
Views
7
CrossRef citations to date
0
Altmetric
Original Investigation

Color Doppler imaging in thyroid eye disease and its correlation to disease activity

Mansooreh Jamshidian-TehraniEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranCorrespondence[email protected]
View further author information
,
Amin NabaviEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranView further author information
,
Abolfazl KasaeeEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranView further author information
,
Narges HasanpoorEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranView further author information
,
Eahsan ElhamiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranView further author information
,
Shervin Sharif-KashaniDepartment of Radiology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IranView further author information
,
Ahamd MasoumiEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranView further author information
,
M. Hossein NowroozzadehPoostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, IranView further author information
&
Ali Sadeghi-TariEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranView further author information
 show all
Pages 440-445 | Received 30 May 2018, Accepted 02 Dec 2018, Published online: 10 Jan 2019

References

  • Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;12:284–290. PMID: 8597271.
  • McAlinden C. An overview of thyroid eye disease. Eye Vis (Lond). 2014;1:9. doi:10.1186/s40662-014-0009-8.
  • Burch HB, Wartofsky L. Graves’ ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 1993;14:747–793. doi:10.1210/edrv-14-6-747.
  • Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 1997;47:9–14.
  • Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158:273–285. doi:10.1530/EJE-07-0666.
  • Yokoyama N, Nagataki S, Uetani M, Ashizawa K, Eguchi K. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Thyroid. 2002;12:223–227. doi:10.1089/105072502753600179.
  • Krassas G, Dumas A, Pontikldes N, Kaltsas T. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol (Oxf). 1995;42:571–580.
  • Gerding MN, Prummel MF, Wiersinga WM. Assessment of disease activity in Graves’ ophthalmopathy by orbital ultrasonography and clinical parameters. Clin Endocrinol (Oxf). 2000;52:641–646. doi:10.1046/j.1365-2265.2000.00973.x.
  • Konuk O, Onaran Z, Ozhan Oktar S, Yucel C, Unal M. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves’ orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol. 2009;247:1555–1559. doi:10.1007/s00417-009-1144-0.
  • Yanik B, Conkbayir I, Acaroglu G, Hekimoglu B. Graves’ ophthalmopathy: comparison of the Doppler sonography parameters with the clinical activity score. J Clin Ultrasound. 2005;33:375–380. doi:10.1002/jcu.20154.
  • Monteiro ML, Angotti-Neto H, Benabou JE, Betinjane AJ. Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves’ orbitopathy. Jpn J Ophthalmol. 2008;52:483–488. doi:10.1007/s10384-008-0594-y.
  • Aburn NS, Sergott RC. Orbital colour Doppler imaging. Eye (Lond). 1993;7:639–647. doi:10.1038/eye.1993.147.
  • Stalmans I, Vandewalle E, Anderson DR, et al. Use of colour Doppler imaging in ocular blood flow research. Acta Ophthalmol. 2011;89:e609–e630. doi:10.1111/j.1755-3768.2011.02178.x.
  • Greenfield DS, Heggerick PA, Hedges TR. Color Doppler imaging of normal orbital vasculature. Ophthalmology. 1995;102:1598–1605.
  • Kaiser HJ, Schötzau A, Flammer J. Blood-flow velocities in the extraocular vessels in normal volunteers. Am J Ophthalmol. 1996;122:364–370.
  • Somer D, Ozkan SB, Ozdemir H, Atilla S, Soylev MF, Duman S. Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease. Jpn J Ophthalmol. 2002;46:341–345. doi:10.1016/S0021-5155(02)00485-9.
  • Monteiro ML, Moritz RB, Angotti Neto H, Benabou JE. Color Doppler imaging of the superior ophthalmic vein in patients with Graves’ orbitopathy before and after treatment of congestive disease. Clinics (Sao Paulo). 2011;66:1329–1334. doi:10.1590/S1807-59322011000800004.
  • Alp MN, Ozgen A, Can I, Cakar P, Gunalp I. Colour Doppler imaging of the orbital vasculature in Graves’ disease with computed tomographic correlation. Br J Ophthalmol. 2000;84:1027–1030. doi:10.1136/bjo.84.9.1027.
  • Perez-Lopez M, Sales-Sanz M, Rebolleda G, et al. Retrobulbar ocular blood flow changes after orbital decompression in Graves’ ophthalmopathy measured by color Doppler imaging. Invest Ophthalmol Vis Sci. 2011;52:5612–5617. doi:10.1167/iovs.10-6907.
  • Tortora F, Cirillo M, Ferrara M, et al. Disease activity in Graves’ ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score. Neuroradiol J. 2013;26:555–564. doi:10.1177/197140091302600509.
  • Boehm AG, Helmke K, Berry CC, Weinreb RN. Comparison of two transducers for color Doppler imaging of the retrobulbar vessels. J Glaucoma. 2002;11:148–153.
  • Prummel MF, Suttorp-Schulten MS, Wiersinga WM, Verbeek AM, Mourits MP, Koornneef L. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy. Ophthalmology. 1993;100:556–561.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.